Welcome to our dedicated page for Amesite SEC filings (Ticker: AMST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Wondering whether Amesite’s AI business has the cash runway to keep innovating, or if executives have been buying shares? This page gathers every SEC disclosure—from an Amesite annual report 10-K simplified to each Amesite Form 4 insider transactions real-time—so you can stop searching EDGAR line by line.
Stock Titan’s AI reads the dense accounting notes and legal language for you. Need the latest Amesite quarterly earnings report 10-Q filing? Our system highlights revenue trends and R&D spend in plain English. Tracking governance? Get instant alerts when a new Amesite proxy statement executive compensation posts. Material news moves quickly; that’s why every Amesite 8-K material events explained section is summarized within seconds of filing.
Use cases:
- Spot patterns in Amesite insider trading Form 4 transactions before the market reacts.
- Compare product development costs quarter-over-quarter with Amesite earnings report filing analysis.
- Prepare questions for management calls by understanding Amesite SEC documents with AI.
Whether you monitor Amesite executive stock transactions Form 4 or dive deep into risk factors, our platform delivers clear, expert context, real-time updates, and AI-powered summaries that turn complex filings into actionable insight.
Amesite (Nasdaq: AMST) filed an 8-K on June 26 2025 announcing a change in its independent auditor.
The Audit Committee dismissed Turner, Stone & Company, whose FY 2024 report contained a going-concern paragraph, and appointed Novogradac & Company effective June 24 2025.
- No disagreements with the former auditor were reported.
- Previously disclosed material weaknesses in internal controls over journal entries, stock-based compensation and deferred revenue remain a reportable event.
- Turner Stone’s concurrence letter is filed as Exhibit 16.1.
The auditor switch may influence audit timelines, remediation efforts and investor perception of financial reporting quality.
FAQ
What is the current stock price of Amesite (AMST)?
What is the market cap of Amesite (AMST)?
What is the primary business of Amesite Inc.?
How does Amesite generate revenue?
Which industries does Amesite primarily serve?
What makes Amesite’s technology unique?
Can you explain the role of NurseMagic™ in Amesite's portfolio?
How does Amesite differentiate itself from competitors?
What is the significance of Amesite's educational solutions?
Who are the primary customers of Amesite Inc.?
